Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial.

Source:http://linkedlifedata.com/resource/pubmed/id/8664192

Download in:

View as

General Info

PMID
8664192